文献速递眼底病与葡萄膜炎

美国大型管理式医疗网络中糖尿病青少年的眼科筛查模式

Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network.
PubMed 文献 · JAMA Ophthalmol · 2017-01-01

这项回顾性纵向队列研究分析了2001至2014年美国管理式医疗网络中21岁及以下新诊断糖尿病青少年,评估其按指南接受眼科检查的比例及相关因素。结果显示,1型糖尿病和2型糖尿病青少年在初诊后6年内接受眼科检查的比例分别为64.9%和42.2%,黑人和拉丁裔青少年及家庭净资产较低者接受检查的可能性更低。

要点

  • 1型糖尿病青少年初诊后6年内接受眼科检查的比例为64.9%,2型糖尿病为42.2%。
  • 黑人青少年(占样本10.8%)接受眼科检查的风险比白人低11%(HR 0.89)。
  • 拉丁裔青少年(占样本11.4%)接受眼科检查的风险比白人低18%(HR 0.82)。

核心结论

  • 尽管拥有医疗保险,许多糖尿病青少年在初诊后6年内未接受眼科检查以监测糖尿病视网膜病变。
  • 数据表明,少数族裔和较不富裕家庭的青少年对临床实践指南的依从性尤其具有挑战性。

研究设计与样本

  • 回顾性纵向队列研究,纳入2001年1月1日至2014年12月31日美国管理式医疗网络中21岁及以下新诊断糖尿病的青少年。
  • 采用Kaplan-Meier生存曲线估计从糖尿病初诊至首次由眼科医生或验光师进行眼科检查的时间。
  • 采用多变量Cox比例风险回归模型识别与初诊后接受眼科检查相关的因素。

主要发现

  • 1型糖尿病青少年共5453例(初诊中位年龄11岁,四分位距8-15岁;男性2972例[54.5%];白人4505例[82.6%]),其中64.9%在初诊后6年内接受过眼科检查。
  • 2型糖尿病青少年共7233例(初诊中位年龄19岁,四分位距16-22岁;男性1196例[16.5%];白人5052例[69.9%]),其中42.2%在初诊后6年内接受过眼科检查。
  • 黑人青少年(占样本10.8%)在6年内接受眼科检查的风险比白人青少年低11%(校正HR 0.89;95%CI 0.79-0.99)。
  • 拉丁裔青少年(占样本11.4%)在6年内接受眼科检查的风险比白人青少年低18%(HR 0.82;95%CI 0.73-0.92)。

关键数值与推荐

  • 美国眼科学会推荐1型糖尿病青少年在糖尿病初诊后5年开始进行糖尿病视网膜病变眼科筛查。
  • 美国糖尿病协会推荐2型糖尿病青少年在初诊时即进行筛查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years after initial diabetes diagnosis for youths with type 1 diabetes; the American Diabetes Association recommends screening of youths with type 2 diabetes at the time of initial diagnosis. To our knowledge, it is unknown to what extent youths with diabetes obtain eye examinations in accordance with these guidelines. OBJECTIVE: To assess the rate of obtaining ophthalmic examinations and factors associated with receipt of eye examinations for youths with diabetes. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, longitudinal cohort study examined youths 21 years or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through December 31, 2014. MAIN OUTCOMES AND MEASURES: Kaplan-Meier survival curves estimated the time from initial diabetes diagnosis to first eye examination by an ophthalmologist or optometrist. Multivariable Cox proportional hazards regression models identified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis. RESULTS: Among 5453 youths with type 1 diabetes (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505 white [82.6%]) and 7233 youths with type 2 diabetes (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 5052 white [69.9%]), 64.9% of patients with type 1 diabetes and 42.2% of patients with type 2 diabetes had undergone an eye examination by 6 years after initial diabetes diagnosis. Black youths (1367 [10.8%] of the sample) had an 11% and Latino youths (1450 [11.4%] of the sample) had an 18% decreased hazard of undergoing an eye examination by 6 years compared with white youths (black youths: adjusted hazard ratio [HR], 0.89; 95% CI, 0.79-0.99; Latino youths: HR, 0.82; 95% CI, 0.73-0.92). As household net worth increased, youths were increasingly more likely to undergo an eye examination by 6 years after initial diabetes diagnosis (net worth of ≥$500 000 vs <$25 000: HR, 1.50; 95% CI, 1.34-1.68). CONCLUSIONS AND RELEVANCE: Despite possessing health insurance, many youths with diabetes are not receiving eye examinations by 6 years after initial diagnosis to monitor for DR. These data suggest that adherence to clinical practice guidelines is particularly challenging for racial minorities and youths from less affluent families.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wang SY, Andrews CA, Gardner TW, et al. Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network. JAMA Ophthalmol. 2017. PMID: 28334336. doi:10.1001/jamaophthalmol.2017.0089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。